David Sherris
Gründer bei Paloma Pharmaceuticals, Inc.
Profil
David Sherris was the founder of Paloma Pharmaceuticals, Inc. which was founded in 2005, where he held the titles of President, CEO, Treasurer & Director.
He held the position of Chief Scientific Officer at RestorGenex Corp.
from 2015 to 2016 and was the President of VasculoMedics, Inc. Dr. Sherris earned a doctorate degree from the University of Utah.
Aktive Positionen von David Sherris
| Unternehmen | Position | Beginn |
|---|---|---|
Paloma Pharmaceuticals, Inc.
 Paloma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Paloma Pharmaceuticals, Inc. manufactures pharmaceutical drugs and related products. The firm’s product Cialis which develops drugs for cancer, ocular diseases, arthritis, fibrotic diseases, antiviral, skin diseases and erectile dysfunction. The company is headquartered in Jamaica Plain, MA. | Gründer | 01.01.2005 |
Ehemalige bekannte Positionen von David Sherris
| Unternehmen | Position | Ende |
|---|---|---|
RestorGenex Corp.
 RestorGenex Corp. Pharmaceuticals: MajorHealth Technology RestorGenex Corp. operates as a specialty biopharmaceutical company, which focuses on developing products for dermatology, ophthalmology, and oncology. It products includes novel PI3K/Akt/mTOR pathway inhibitor which has completed two Phase I clinical trials for age-related macular degeneration and is in preclinical development in oncology, specifically glioblastoma multiforme. The company current pipeline also includes a soft anti-androgen compound for the treatment of acne vulgaris. RestorGenex was founded on March 14, 2008 and is headquartered in Buffalo Grove, IL. | Technik-/Wissenschafts-/F&E-Leiter | 08.01.2016 |
VasculoMedics, Inc.
 VasculoMedics, Inc. BiotechnologyHealth Technology Part of CervoMed, Inc., VasculoMedics, Inc. is a company that produces and develops zinc finger transcription factors for medical use. The company is based in Jamaica Plain, MA. VasculoMedics was acquired by Stratus Media Group, Inc. on March 28, 2014 for $1.39 million. | Präsident | - |
Ausbildung von David Sherris
| University of Utah | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
RestorGenex Corp.
RestorGenex Corp. Pharmaceuticals: MajorHealth Technology RestorGenex Corp. operates as a specialty biopharmaceutical company, which focuses on developing products for dermatology, ophthalmology, and oncology. It products includes novel PI3K/Akt/mTOR pathway inhibitor which has completed two Phase I clinical trials for age-related macular degeneration and is in preclinical development in oncology, specifically glioblastoma multiforme. The company current pipeline also includes a soft anti-androgen compound for the treatment of acne vulgaris. RestorGenex was founded on March 14, 2008 and is headquartered in Buffalo Grove, IL. | Health Technology |
Paloma Pharmaceuticals, Inc.
Paloma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Paloma Pharmaceuticals, Inc. manufactures pharmaceutical drugs and related products. The firm’s product Cialis which develops drugs for cancer, ocular diseases, arthritis, fibrotic diseases, antiviral, skin diseases and erectile dysfunction. The company is headquartered in Jamaica Plain, MA. | Health Technology |
VasculoMedics, Inc.
VasculoMedics, Inc. BiotechnologyHealth Technology Part of CervoMed, Inc., VasculoMedics, Inc. is a company that produces and develops zinc finger transcription factors for medical use. The company is based in Jamaica Plain, MA. VasculoMedics was acquired by Stratus Media Group, Inc. on March 28, 2014 for $1.39 million. | Health Technology |
